Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
Sales rise 15.97% to Rs 1401.71 crore
Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as against Rs 194.10 crore during the previous quarter ended June 2023. Sales rose 15.97% to Rs 1401.71 crore in the quarter ended June 2024 as against Rs 1208.69 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1401.711208.69 16 OPM %18.8624.32 -PBDT310.21326.58 -5 PBT218.25261.27 -16 NP143.76194.10 -26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 06 2024 | 5:16 PM IST